New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma
Condition(s):AsthmaLast Updated:June 23, 2011Completed
Hide Studies Not Open or Pending
Condition(s):AsthmaLast Updated:June 23, 2011Completed
Condition(s):Ischemic Heart Disease; Acute Coronary SyndromesLast Updated:October 14, 2009Completed
Condition(s):Eosinophilic EsophagitisLast Updated:March 12, 2013Completed
Condition(s):Asthma; COPDLast Updated:March 27, 2020Completed
Condition(s):HealthyLast Updated:June 22, 2007Completed
Condition(s):Allergic Conjunctivitis to Tree Pollen or Grass PollenLast Updated:December 3, 2012Completed
Condition(s):Oral Chronic Graft vs Host DiseaseLast Updated:January 21, 2016Completed
Condition(s):COPDLast Updated:March 29, 2019Completed
Condition(s):AsthmaLast Updated:April 6, 2012Completed
Condition(s):Hemodialysis Patients; Peripheral Vascular DiseaseLast Updated:May 12, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.